Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin e Cancer Prevention Trial (SELECT)

Cancer Prevention Research

Volumn 7, Issue 9, 2014, Pages 886-895

  Albanes, Demetrius ^a   Till, Cathee ^b   Klein, Eric A ^c   Goodman, Phyllis J ^b   Mondul, Alison M ^a   Weinstein, Stephanie J ^a   Taylor, Philip R ^a   Parnes, Howard L ^a   Gaziano, J Michael ^d   Song, Xiaoling ^b   Fleshner, Neil E ^e   Brown, Powel H ^f   Meyskens, Frank L ^g   Thompson, Ian M ^h  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d VA BOSTON HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h San Antonio Cancer Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; GAMMA TOCOPHEROL; PLACEBO; PROSTATE SPECIFIC ANTIGEN; SELENOMETHIONINE; SELENIUM; TOCOPHEROL;

ADULT; ARTICLE; CALCIUM INTAKE; CALORIC INTAKE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FAT INTAKE; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; AGED; BLOOD; CASE CONTROL STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MIDDLE AGED; PROSTATE TUMOR; RISK FACTOR;

AGED; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOUBLE-BLIND METHOD; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK FACTORS; SELENIUM; TOCOPHEROLS;

EID: 84907299493     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-14-0058     Document Type: Article

References (44)

1. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440-6.
2. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, et al. Effect of seleniumand vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009;301:39-51.
3. Klein EA, Thompson IM, Tangen CM, Crowley JJ, Lucia M, Goodman PJ, et al. Vitamin E and the risk of prostate cancer. The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011;306: 1549-56.
4. Gaziano JM, Glynn RJ, Christen WG, Kurth T, Belanger C, MacFadyen J, et al. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA 2009;301:52-62.
5. Eichholzer M, Stahelin HB, Gey KF, Ludin E, Bernasconi F. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int J Cancer 1996; 66:145-50.
6. Goodman GE, Schaffer S, Omenn GS, Chen C, King I. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev 2003;12:518-26.
7. Weinstein SJ, Wright ME, Pietinen P, King I, Tan C, Taylor PR, et al. Serum alpha-tocopherol andgamma-tocopherol in relation to prostate cancer risk in a prospective study. J Natl Cancer Inst 2005;97:396-9.
8. Weinstein SJ, Wright ME, Lawson KA, Snyder K, Mannisto S, Taylor PR, et al. Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007;16:1253-9.
9. Watters JL, Gail MH, Weinstein SJ, Virtamo J, Albanes D. Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival. Cancer Res 2009;69:3833-41.
10. Cheng T, Barnett MJ, Kristal AE, Ambrosone CB, King IB, Thornquist MD, et al. Genetic variation in myeloperoxidase modifies the association of serum alpha-tocopherol with aggressive prostate cancer among current smokers. J Nutr 2011;141:1731-7.
11. Chan JM, Stampfer MJ, Ma J, Rimm EB, Willett WC, Giovannucci EL. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev 1999;8:893-9.
12. Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 1999; 59:1225-30.
13. Weinstein SJ, Peters U, Ahn J, Friesen MD, Riboli E, Hayes RB, et al. Serum alpha-tocopherol and gamma-tocopherol concentrations and prostate cancer risk in thePLCOScreening Trial: a nested case-control study. PLoS ONE 2012;7:e40204
14. Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM Jr, Kristal AR, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst 2005;97:94-102.
15. Goodman PJ, Hartline JA, Tangen CM, Crowley JJ, Minasian LM, Klein EA, et al. Moving a randomized clinical trial into an observational cohort. Clin Trials 2013;10:131-42.
16. Hoque A, Albanes D, Lippman SM, Spitz MR, Taylor PR, Klein EA, et al. Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Causes Control 2001;12: 627-33.
17. Brasky TM, Till C, White E, Neuhouser ML, Song X, Goodman P, et al. Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol 2011;173: 1429-39.
18. Kristal AR, Till C, Platz EA, Song X, King IB, Neuhouser ML, et al. Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev 2011;20:638-46.
19. Barlow WE. Robust variance estimation for the case-cohort design. Biometrics 1994;50:1064-72.
20. Barlow WE, Ichikawa L, Rosner D, Izumi S. Analysis of case-cohort designs. J Clin Epidemiol 1999;52:1165-72.
21. Lin DY, Wei LJ, Ying Z. Checking the cox model with cumulative sums of Martingale-based residuals. Biometrika 1993;80:557-72.
22. Ford ES, Schleicher RL, Mokdad AH, Ajani UA, Liu S. Distribution of serum concentrations of alpha-tocopherol and gamma-tocopherol in the US population. Am J Clin Nutr 2006;84:375-83.
23. Takahashi S, Takeshita K, Seeni A, Sugiura S, Tang M, Sato SY, et al. Suppression of prostate cancer in a transgenic rat model via gamma-tocopherol activation of caspase signaling. Prostate 2009; 69:644-51.
24. Major JM, Yu K, Wheeler W, Zhang H, Cornelis MC, Wright ME, et al. Genome-wide association study identifies common variants associated with circulating vitamin E levels. Hum Mol Genet 2011;20: 3876-83.
25. Ricciarelli R, Zingg JM, Azzi A. Vitamin E: protective role of a Janus molecule. FASEB J 2001;15:2314-25.
26. Fleshner NE. Vitamin E and prostate cancer. Urol Clin North Am 2002;29:107-13.
27. Hartman TJ, Dorgan JF, Woodson K, Virtamo J, Tangrea JA, Heinonen OP, et al. Effects of long-term alpha-tocopherol supplementation on serum hormones in older men. Prostate 2001;46:33-8.
28. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academy Press; 2000.
29. Venkateswaran V, Klotz LH. Diet and prostate cancer: mechanisms of action and implications for chemoprevention. Nat Rev Urol 2010; 7:442-53.
30. Basu A, Grossie B, Bennett M, Mills N, Imrhan V. Alpha-tocopheryl succinate (alpha-TOS) modulates human prostate LNCaP xenograft growth and gene expression in BALB/c nude mice fed two levels of dietary soybean oil. Eur J Nutr 2007;46:34-43.
31. Schindler R, Mentlein R. Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells. J Nutr 2006;136:1477-82.
32. Key TJ, Appleby PN, Allen NE, Travis RC, Roddam AW, Jenab M, et al. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr 2007;86:672-81.
33. Gill JK, Franke AA, Steven MJ, Cooney RV, Wilkens LR, Le ML, et al. Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort. Cancer Causes Control 2009;20: 1161-71.
34. Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, Helzlsouer KJ. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol 2003;157:335-44.
35. Helzlsouer KJ, Huang HY, Alberg AJ, Hoffman S, Burke A, Norkus EP, et al. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 2000; 92:2018-23.
36. Nomura AM, Stemmermann GN, Lee J, Craft NE. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 1997;6:487-91.
37. Knekt P, Aromaa A, Maatela J, Aaran RK, Nikkari T, Hakama M, et al. Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. Am J Epidemiol 1988;127:28-41.
38. Hayes RB, Bogdanovicz JF, Schroeder FH, De Bruijn A, Raatgever JW, Van der Maas PJ, et al. Serum retinol and prostate cancer. Cancer 1988;62:2021-6.
39. Zu K, Ip C. Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells. Cancer Res 2003;63:6988-95.
40. Venkateswaran V, Fleshner NE, Klotz LH. Synergistic effect of vitamin E and selenium in human prostate cancer cell lines. Prostate Cancer Prostatic Dis 2004;7:54-6.
41. Stabler S, Koyama T, Zhao Z, Martinez-Ferrer M, Allen RH, Luka Z, et al. Serum methionine metabolites are risk factors for metastatic prostate cancer progression. PLoS ONE 2011;6:e22486
42. Stawiarska-Pieta B, Bielec B, Birkner K, Birkner E. The influence of vitamin E and methionine on the activity of enzymes and the morphological picture of liver of rats intoxicated with sodium fluoride. Food Chem Toxicol 2012;50:972-8.
43. Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, et al. Dietary supplement use in the United States, 2003-2006. J Nutr 2011;141:261-6.
44. Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ, et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 2003;290:476-85.